AMLX vs POOL · rev $87.4M vs P/E 18, rev $5.31B
Amylyx Pharmaceuticals Inc (AMLX) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported AMLX revenue for 2024-12-31 was $87.4M. Net income was -$301.7M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AMLX currently screens at market cap $561.6M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
AMLX currently screens at market cap $561.6M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the AMLX and POOL stock pages for the full models.
Not investment advice.